雜志介紹

Ejnmmi Research雜志介紹

《Ejnmmi Research》是一本以English為主的開放獲取國際優秀期刊，中文名稱恩米研究，本刊主要出版、報道醫學-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.1，最新CiteScore 指數為5.9。

本刊近期中國學者發表的論文主要有：

• CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size

  Author: Wei, Hua; Wu, Jiaojiao; Han, Ke; Hu, Guang; Wang, Hongliang; Guo, Xiaoshan; Liu, Haiyan; Wu, Zhifang; Li, Sijin

• Predicting PD-L1 expression status in patients with non-small cell lung cancer using [F-18]FDG PET/CT radiomics

  Author: Zhao, Xiaoqian; Zhao, Yan; Zhang, Jingmian; Zhang, Zhaoqi; Liu, Lihua; Zhao, Xinming

• Direct reconstruction for simultaneous dual-tracer PET imaging based on multi-task learning

  Author: Zeng, Fuzhen; Fang, Jingwan; Muhashi, Amanjule; Liu, Huafeng

• The potential application of MR-derived ADCmin values from Ga-68-DOTATATE and F-18-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors

  Author: Gao, Jing; Xu, Si; Ju, Huijun; Pan, Yu; Zhang, Yifan

英文介紹

Ejnmmi Research雜志英文介紹

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.

The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.